Lipid peroxidation in systemic lupus erythematosus

Indian Journal of Experimental Biology

Volumn 44, Issue 5, 2006, Pages 349-356

  Kurien, Biji T ^a,d   Scofield, R Hal ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Antigens; Autoantibody; Autoimmunity; Epitopes; Lupus

Indexed keywords

FREE RADICAL;

ANIMAL; HUMAN; LIPID PEROXIDATION; METABOLISM; MOUSE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

ANIMALIA;

EID: 33646569106     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Taube H, Mechanisms of oxidation with oxygen, J Gen Physiol, 49 (1965) Suppl.
2. Hamilton G A, Mechanisms of two- and four-electron oxidations catalyzed by some metalloenzymes, Adv Enzymol Relat Areas Mol Biol, 32 (1969) 55.
3. Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B & Nagy J, Oxidative stress and antioxidant defense mechanism in glomerular diseases, Free Radic Biol Med, 22 (1997) 161.
4. Serban M G, Tanaseanu S & Bara C, Oxidant stress and antioxidant protection in lupus nephropathy, Rom J Intern Med, 34 (1996) 105.
5. Fridovich I, in Molecular mechanism of oxygen activation, edited by O Hayaishi, (Acad. Press, New York) 1974, 453.
6. Walling C, in Oxidases and related redox systems, edited by T E King, H S Mason & M Morrison (Pergamon Press, Oxford) 1982, 85.
7. Steinman H M & Ely B, Copper-zinc superoxide dismutase of Caulobacter crescentus: Cloning, sequencing, and mapping of the gene and periplasmic location of the enzyme, J Bacteriol, 172 (1990) 2901.
8. Michel P, Eggert W, Albrecht-Nebe H & Grune T, Increased lipid peroxidation in children with autoimmune diseases, Acta Paediat, 86 (1997) 609.
9. Serban M G & Tanaseanu S, Lipid peroxidation in autoimmune systemic vasculitides. Effect of corticoid treatment on lipid peroxidation. Antioxidant protection with vitamin E, Rom J Intern Med, 32 (1994) 137.
10. Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H & Siems W G, Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases, Free Radic Biol Med, 23 (1997) 357.
11. Kurien B T & Scofield R H, Free radical mediated peroxidative damage in systemic lupus erythematosus, Life Sci, 73 (2003) 1655.
12. Tipple A N L, Lipid per oxidation damage to cell components, Fed Proc, 32 (1973) 1870.
13. Rim Bach G, Holler D, Fischer A, Roy S, Virgil F, Pallauf J & Packer L, Methods to assess free radicals and oxidative stress in biological systems, Arch Tierernahr, 52 (1999) 203.
14. Pratico D, F(2)-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo, Atherosclerosis, 147 (1999) 1.
15. Camandola S, Poli G & Mattson M P, The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons, J Neurochem, 74 (2000) 159.
16. Hartley D P, Kroll D J & Petersen D R, Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: Detection of 4-hydroxynonenal- and malondialdehyde-protein adducts, Chem Res Toxicol, 10 (1997) 895.
17. Calingasan N Y, Uchida K & Gibson G E, Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease, J Neurochem, 72 (1999) 751.
18. Klein R A, The detection of oxidation in liposome preparations, Biochim Biophys Acta, 210 (1970) 486.
19. Singh R B, Shinde S N, Chopra R K, Niaz M A, Thakur A S & Onouchi Z, Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits, Atherosclerosis, 148 (2000) 275.
20. Levine R L, Garland D, Oliver C N, Amici A, Climent I, Lenz A G, Ahn B W, Shaltiel S & Stadtman E R, Determination of carbonyl content in oxidatively modified proteins, Methods Enzymol, 186 (1990) 464.
21. Reznick A Z, Cross C E, Hu M L, Suzuki Y J, Khwaja S, Safadi A, Motchnik P A, Packer L & Halliwell B, Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation, Biochem J, 286 (Pt 2) (1992) 607.
22. Arbuckle M R, McClain M T, Rubertone M V, Scofield R H, Dennis G J, James J A & Harley J B, Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N Engl J Med, 349 (2003) 1526.
23. Scofield R H, Autoantibodies as predictors of disease, Lancet, 363 (2004) 1544.
24. Schur P H & Sandson J, Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med; 278 (1968) 533.
25. Egner W, The use of laboratory tests in the diagnosis of SLE, J Clin Pathol, 53 (2000) 424.
26. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K & Palosuo T, Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet, 341 (1993) 923.
27. Craig W, Autoantibodies against oxidized low density lipoprotein: A review of clinical findings and assay methodology. J Clin Lab Anal, 9 (1995) 70.
28. Steinerova A, Stozicky F, Racek J, Tatzber F, Zima T & Setina R, Antibodies against oxidized LDL in infants, Clin Chem, 47 (2001) 1137.
29. Vaarala O, Antibodies to oxidised LDL. Lupus, 9 (2000) 202.
30. Farris A D, Gross J K, Hanas J S & Harley J B, Genes for murine Y1 and Y3 Ro RNAs have class 3 RNA polymerase III promoter structures and are unlinked on mouse chromosome 6, Gene, 174 (1996) 35.
31. O'Brien C A & Wolin S L, A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors, Genes Dev, 8 (1994) 2891.
32. Yamagata H, Harley J B & Reichlin M, Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody, J Clin Invest, 74 (1984) 625.
33. Boyd G W, An evolution-based hypothesis on the origin and mechanisms of autoimmune disease, Immunol Cell Biol, 75 (1997) 503.
34. Rose N R & Mackay I R, Molecular mimicry: A critical look at exemplary instances in human diseases, Cell Mol Life Sci, 57 (2000) 542.
35. Scofield R H, Henry W E, Kurien B T, James J A & Harley J B, Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity, J Immunol, 156 (1996) 4059.
36. Scofield R H, Kaufman K M, Baber U, James J A, Harley J B & Kurien B T, Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse, Arthritis Rheum, 42 (1999) 1017.
37. James J A, Gross T, Scofield R H & Harley J B, Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity, J Exp Med, 181 (1995) 453.
38. Scofield R H, Pierce P G, James J A, Kaufman K M & Kurien B T, Immunization with peptides from 60 kDa Ro in diverse mouse strains. Scand J Immunol, 56 (2002) 477.
39. Suryaprabha P, Das U N, Ramesh G, Kumar K V & Kumar G S, Reactive oxygen species, lipid peroxides and essential fatty acids in patients with arthritis and systemic lupus erythematosus, Prostaglandins Leukot Essent Fatty Acids, 43 (1991) 251.
40. Das U N, Oxidants, antioxidants, essential fatty acids, eicosanoids, cytokines, gene/oncogene expression and apoptosis in systemic lupus erythematosus. J Assoc Physic India, 46 (1998) 630.
41. Mosaad Y M, Metwally S S, Auf F A, AbdEL-Samee E R, el-Deek B, Limon N I & el-Chennawi F A, Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: Relation with disease activity and autoantibodies production. Egypt J Immunol, 10 (2003) 19.
42. Serban M G, Balanescu E & Nita V, Lipid peroxidase and erythrocyte redox system in systemic vasculitides treated with corticoids. Effect of vitamin E administration. Rom J Intern Med, 32 (1994) 283.
43. Jiang X & Chen F, The effect of lipid peroxides and superoxide dismutase on systemic lupus erythematosus: A preliminary study, Clin Immunol Immunopathol, 63 (1992) 39.
44. Mohan I K & Das U N, Oxidant stress, antioxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids, 56 (1997) 193.
45. Mohan I K & Das U N, Oxidant stress, antioxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids, 56 (1997) 193.
46. Pottathil R, Huang S W & Chandrabose K A, Essential fatty acids in diabetes and systemic lupus erythematosus (SLE) patients. Biochem Biophys Res Commun, 128 (1985) 803.
47. Waris G & Alam K, Immunogenicity of superoxide radical modified-DNA: Studies on induced antibodies and SLE anti-DNA autoantibodies, Life Sci, 75 (2004) 2633.
48. Garg D K & Moinuddin Ali R, Hydroxyl radical modification of polyguanylic acid: Role of modified guanine in circulating SLE anti-DNA autoantibodies, Immunol Invest, 32 (2003) 187.
49. Serban M G & Negru T, Antioxidant protection in collagen-vascular diseases. Rom J Intern Med, 36 (1998) 245.
50. Agisheva K N & Salikhov I G, [Lipid peroxidation and state of antioxidant system in patients with systemic lupus erythematosus] Klin Med (Mosk), 68 (1990) 99. Russian.
51. Tam L S, Li E K, Leung V Y, Griffith J F, Benzie I F, Lim P L, Whitney B, Lee V W, Lee K K, Thomas G N & Tomlinson B, Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: A double blind, placebo controlled pilot study, J Rheumatology, 32 (2005) 275.
52. Abou-Raya A, el-Hallous D & Fayed H, 8-Isoprostaglandin F2 alpha: A potential index of lipid peroxidation in systemic lupus erythematosus. Clin Invest Med, 27 (2004) 306.
53. Ames P R, Alves J, Murat I, Isenberg D A & Nourooz-Zadeh J, Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement, Rheumatology (Oxford), 38 (1999) 529.
54. Taysi S, Gul M, Sari R A, Akcay F & Bakan N, Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med, 40 (2002) 684.
55. Denko C W & Gabriel P, Serum proteins - transferrin, ceruloplasmin, albumin, alpha 1-acid glycoprotein, alpha 1-antitrypsin - in rheumatic disorders. J Rheumatol, 6 (1979) 664.
56. Surrall K E, Bird H A & Dixon J S. Caeruloplasmin, prealbumin and alpha 2- macroglobulin as potential indices of disease activity in different arthritides. Clin Rheumatol, 6 (1987) 64.
57. Yilmaz A, Sari R A, Gundogdu M, Kose N & Dag E. Trace elements and some extracellular antioxidant proteins levels in serum of patients with systemic lupus erythematosus, Clin Rheumatol, 24 (2005) 331.
58. Yamagata H, Harley J B & Reichlin M, Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody, J Clin Invest, 74 (1984) 625.
59. Scofield R H, Kurien B T, Zhang F, Mehta P, Kaufman K, Gross T, Bachmann M, Gordon T & Harley J B. Protein-protein interaction of the Ro-ribonucleoprotein particle using multiple antigenic peptides. Mol Immunol, 36 (1999) 1093.
60. Scofield R H, Kurien B T, Gross J K, Reed N B, Taylor A K, Dominguez N, Mehta P, Guthridge J M & Bachmann M. Interaction of calcium and Ro60:increase of antigenicity. Mol Immunol, 41 (2004) 809.
61. Kurien B T, Asfa S, Li C, Dorri Y, Jonsson R & Scofield R H, Induction of oral tolerance in experimental Sjogren's syndrome autoimmunity. Scand J Immunol, 61 (2005) 418.
62. Kurien B T, Jackson K & Scofield R H, Immunoblotting of multiple antigenic peptides. Electrophoresis, 19 (1998) 1659.
63. Scofield R H, Kurien B T, Ganick S, McClain M T, Pye Q, James J A, Schneider R I, Broyles R H, Bachmann M & Hensley K, Modification of lupus-associated 60- kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med, 38 (2005) 719.
64. Kurien B T & Scofield R H. In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants, J Immunol Methods, 303 (2005) 66.
65. Gutteridge J M C, Westermarck T & Halliwell B, Oxygen radical damage in biological systems. In Free radicals, aging, and degenerative diseases, edited by J E Johnson, R Walford, D Harman and J Miquel, (Alan R. Liss, New York) 1985, 99.